Download full-text PDF

Source

Publication Analysis

Top Keywords

fate stable
4
stable chromosomal
4
chromosomal aberrations
4
fate
1
chromosomal
1
aberrations
1

Similar Publications

A mutual prodrug of sertraline-methylpropyphenazone (SER-MP) was prepared and characterized using a spectral method. The yield of the prepared SER-MP was 90%, and its purity reached 98.8%.

View Article and Find Full Text PDF

Recent advancements in tissue engineering and regenerative medicine have introduced promising strategies to address tissue and organ deficiencies. This review highlights the critical role of short peptides, particularly their ability to self-assemble into matrices that mimic the extracellular matrix (ECM). These low molecular weight peptides exhibit target-specific activities, modulate gene expression, and influence cell differentiation pathways.

View Article and Find Full Text PDF

Uptake, Subcellular Distribution, and Metabolism of Decabromodiphenyl Ethane in Vegetables under Different Exposure Scenarios.

Environ Sci Technol

January 2025

Institute of Nuclear Agricultural Sciences, Key Laboratory of Nuclear Agricultural Sciences of Ministry of Agriculture of PRC, Zhejiang University, Hangzhou 310058, China.

Decabromodiphenyl ethane (DBDPE), a key alternative to deca-BDE (BDE-209), has been ubiquitous in the receiving ecosystem. However, little is known about its uptake process and fate in plants. Here, the plant absorption, distribution, and metabolism of C-DBDPE under two distinct exposure pathways (i.

View Article and Find Full Text PDF

In the frame of developing a sustainable chemical industry, heterogeneously catalyzed CO2 hydrogenation to methanol has attracted considerable interest. However, the Cu-Zn based catalyst system employed in this process is very dynamic, especially in the presence of the products methanol and water. Deactivation needs to be prevented, but its origin and mechanism are hardly investigated at high conversion where product condensation is possible.

View Article and Find Full Text PDF

We report the basal cell cancer (BCC) cohort of the SWOG/NCI 1609 Dual Anti-CTLA-4 & Anti-PD-1 blockade in Rare Tumors (DART), a phase II prospective, multicenter basket trial of nivolumab and ipilimumab. The primary endpoint was objective response rate (ORR) (RECIST v1.1).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!